Sourcebio International PLC
LSE:SBI
Sourcebio International PLC
LSE:SBI
Price:
115 GBX
4.55%
Market Closed
Updated:
May 5, 2024
Sourcebio International PLC
Operating Income
|
Sourcebio International PLC
Operating Income Peer Comparison
Comparables:
KOO
G
GENI
TLY
T
TRLS
MGP
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sourcebio International PLC
LSE:SBI
|
Operating Income
£21.1m
|
CAGR 3-Years
168%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kooth PLC
LSE:KOO
|
Operating Income
-£2.3m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-103%
|
CAGR 10-Years
N/A
|
|
G
|
Genincode PLC
LSE:GENI
|
Operating Income
-£5.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Totally PLC
LSE:TLY
|
Operating Income
£347k
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
T
|
Trellus Health PLC
LSE:TRLS
|
Operating Income
-$8.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Medica Group PLC
LSE:MGP
|
Operating Income
£9.3m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
See Also
What is Sourcebio International PLC's Operating Income?
Operating Income
21.1m
GBP
21.1m
GBP
Based on the financial report for Dec 31, 2021, Sourcebio International PLC's Operating Income amounts to 21.1m GBP.
What is Sourcebio International PLC's Operating Income growth rate?
Operating Income CAGR 3Y
168%
168%
Over the last year, the Operating Income growth was 74%. The average annual Operating Income growth rates for Sourcebio International PLC have been 168% over the past three years .
You don't have any saved screeners yet
